Literature DB >> 28570794

Usual Course of Treatment and Predictors of Treatment Utilization for Patients With Posttraumatic Stress Disorder.

Carrie J Nobles1,2, Sarah E Valentine1,2, E David Zepeda3, Emily M Ahles1, Derri L Shtasel2,4, Luana Marques5,1,2.   

Abstract

OBJECTIVE: Posttraumatic stress disorder (PTSD) is a debilitating psychiatric illness that frequently remains undiagnosed and untreated. While extensive research has been conducted among veterans, little research has evaluated course of treatment for PTSD in a general hospital setting.
METHODS: We utilized data from the Partners HealthCare Research Patient Data Registry to evaluate mental health treatment utilization, including psychotherapy and pharmacotherapy, by patients with recently diagnosed primary PTSD following DSM-IV criteria between January 1, 2002, and June 30, 2011. We additionally evaluated predictors of treatment utilization 6 months postdiagnosis.
RESULTS: Among 2,475 patients with recently diagnosed primary PTSD, approximately half (55.7%) had any therapy visit and 10% had at least 12 therapy visits in the 6 months following diagnosis. Approximately half (47.0%) received a psychiatric prescription, with 29.3% receiving a selective serotonin reuptake inhibitor (SSRI), 11.8% receiving an atypical antipsychotic, and 24.4% receiving a benzodiazepine. Latinos were 25% (95% CL = 1.09, 1.43) more likely to have an SSRI prescription, 35% (95% CL = 1.05, 1.75) more likely to have an atypical antipsychotic prescription, and 28% (95% CL = 1.19, 1.38) more likely to receive any psychotherapy. Women were 49% (95% CL = 0.42, 0.63) less likely to have an atypical antipsychotic prescription. Patients with Medicare were 23% (95% CL = 0.67, 0.88) less likely to have any psychotherapy, and patients with Medicaid were 35% (95% CL = 0.46, 0.92) less likely to have 12 or more therapy visits.
CONCLUSIONS: Many patients with a primary diagnosis of PTSD do not receive psychotherapy, and psychiatric prescriptions, including atypical antipsychotics and benzodiazepines, are common. Future research is needed to determine the quality of care received and explore subpopulation-specific barriers limiting access to care. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28570794      PMCID: PMC5454778          DOI: 10.4088/JCP.16m10904

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  24 in total

1.  Evidence-based psychotherapy (EBP) non-initiation among veterans offered an EBP for posttraumatic stress disorder.

Authors:  Stephanie M Keller; Peter W Tuerk
Journal:  Psychol Serv       Date:  2015-12-14

2.  Antipsychotic prescriptions in Iraq and Afghanistan veterans with posttraumatic stress disorder in Department of Veterans Affairs healthcare, 2007-2012.

Authors:  Beth E Cohen; Ying Shi; Thomas C Neylan; Shira Maguen; Karen H Seal
Journal:  J Clin Psychiatry       Date:  2015-04       Impact factor: 4.384

Review 3.  Evidence-based treatment of post-traumatic stress disorder.

Authors:  JoAnn Difede; Megan Olden; Judith Cukor
Journal:  Annu Rev Med       Date:  2014       Impact factor: 13.739

4.  Barriers and facilitators of treatment for depression in a latino community: a focus group study.

Authors:  Lisa A Uebelacker; Beth A Marootian; Paul A Pirraglia; Jennifer Primack; Patrick M Tigue; Ryan Haggarty; Lavinia Velazquez; Jennifer J Bowdoin; Zornitsa Kalibatseva; Ivan W Miller
Journal:  Community Ment Health J       Date:  2011-01-26

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Stigma, help-seeking attitudes, and use of psychotherapy in veterans with diagnoses of posttraumatic stress disorder.

Authors:  Craig S Rosen; Mark A Greenbaum; Julie E Fitt; Charlene Laffaye; Virginia A Norris; Rachel Kimerling
Journal:  J Nerv Ment Dis       Date:  2011-11       Impact factor: 2.254

7.  Delivering cognitive processing therapy in a community health setting: The influence of Latino culture and community violence on posttraumatic cognitions.

Authors:  Luana Marques; Elizabeth H Eustis; Louise Dixon; Sarah E Valentine; Christina P C Borba; Naomi Simon; Debra Kaysen; Shannon Wiltsey-Stirman
Journal:  Psychol Trauma       Date:  2015-05-11

8.  Treatment initiation and dropout from prolonged exposure and cognitive processing therapy in a VA outpatient clinic.

Authors:  Shannon M Kehle-Forbes; Laura A Meis; Michele R Spoont; Melissa A Polusny
Journal:  Psychol Trauma       Date:  2015-06-29

9.  Are there racial/ethnic disparities in VA PTSD treatment retention?

Authors:  Michele R Spoont; David B Nelson; Maureen Murdoch; Nina A Sayer; Sean Nugent; Thomas Rector; Joseph Westermeyer
Journal:  Depress Anxiety       Date:  2014-11-24       Impact factor: 6.505

10.  English language proficiency and mental health service use among Latino and Asian Americans with mental disorders.

Authors:  Amy M Bauer; Chih-Nan Chen; Margarita Alegría
Journal:  Med Care       Date:  2010-12       Impact factor: 2.983

View more
  7 in total

1.  Implementation and Utility of an Automated Text Messaging System to Facilitate Symptom Self-Monitoring and Identify Risk for Post-Traumatic Stress Disorder and Depression in Trauma Center Patients.

Authors:  Brian E Bunnell; Tatiana M Davidson; Jennifer R Winkelmann; Jessica L Maples-Keller; Leigh E Ridings; Jennifer Dahne; Samir M Fakhry; Kenneth J Ruggiero
Journal:  Telemed J E Health       Date:  2019-02-07       Impact factor: 3.536

2.  Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.

Authors:  David J Cote; John L Kilgallon; Noah L A Nawabi; Hassan Y Dawood; Timothy R Smith; Ursula B Kaiser; Edward R Laws; JoAnn E Manson; Meir J Stampfer
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

3.  Increased Prevalence of Metabolic Syndrome in Veterans with PTSD Untreated with Antipsychotic Medications.

Authors:  Barton W Palmer; Catherine Shir; Hang Chang; Mallory Mulvaney; Joshua M H Hall; I-Wei Shu; Hua Jin; James B Lohr
Journal:  Int J Ment Health       Date:  2021-08-25

4.  Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder.

Authors:  Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Ruth A Engelberg; David H Au; Eric J Hawkins
Journal:  Ann Am Thorac Soc       Date:  2019-01

5.  Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy.

Authors:  Hwallip Bae; Daeho Kim; Yubin Cho; Dongjoo Kim; Seok Hyeon Kim
Journal:  J Korean Med Sci       Date:  2018-11-05       Impact factor: 2.153

6.  A Systematic Chart Review of Adults with Post-Traumatic Stress Disorder: Data from a Tertiary Care Psychiatry Center in India.

Authors:  K Krishnakumari; Manjula Munivenkatappa; Shantala Hegde; Kesavan Muralidharan
Journal:  Indian J Psychol Med       Date:  2021-10-03

7.  Comparisons Between Patients Diagnosed with PTSD in Primary Care Versus Mental Health Care in Five Large Civilian Health Care Systems.

Authors:  Joan M Cook; John E Zeber; Vanessa Simiola; Rebecca Rossom; Jeffrey F Scherrer; Ashli A Owen-Smith; Brian K Ahmedani; Kiumars Zolfaghari; Laurel A Copeland
Journal:  J Clin Psychol Med Settings       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.